PhD candidate at The Netherlands Organization for Applied Scientific Research (TNO; department Metabolic Health Research) and Leiden University Medical Center (LUMC; department Cardiology).

Contributions

The bispecific anti-FGFR1/KLB agonist antibody bFKB1 attenuates non-alcoholic steatohepatitis and atherosclerosis in Ldlr-/-.Leiden mice91th EAS Congress 2023Late Breaker - Basic Science